keyword
https://read.qxmd.com/read/38688606/stage-migration-in-canine-multicentric-lymphoma-impact-of-diagnostic-techniques-on-assessing-disease-extent
#1
JOURNAL ARTICLE
Maria Teresa Pinto, Isabel Portillo, Juan Borrego, Felisbina L Queiroga
BACKGROUND/AIM: Stage migration, a phenomenon triggered by technological advancements allowing more sensitive tumor spread detection, results in alterations in the distribution of cancer stages within a population. Canine multicentric lymphoma is staged I to V based on the affected anatomic site(s) and substage a or b depending on the presence of tumor-related clinical signs. The primary objective of this study was to assess the influence of various diagnostic techniques on staging accuracy and determine whether multiple staging methods lead to significant stage migration, impacting the reliability of disease stage assignments...
2024: In Vivo
https://read.qxmd.com/read/38686346/automated-layer-analysis-alan-an-image-analysis-tool-for-the-unbiased-characterization-of-mammalian-epithelial-architecture-in-culture
#2
JOURNAL ARTICLE
Christian Cammarota, Dan T Bergstralh, Tara M Finegan
Cultured mammalian cells are a common model system for the study of epithelial biology and mechanics. Epithelia are often considered as pseudo-two dimensional and thus imaged and analyzed with respect to the apical tissue surface. We found that the three-dimensional architecture of epithelial monolayers can vary widely even within small culture wells, and that layers that appear organized in the plane of the tissue can show gross disorganization in the apical-basal plane. Epithelial cell shapes should be analyzed in 3D to understand the architecture and maturity of the cultured tissue to accurately compare between experiments...
April 20, 2024: Bio-protocol
https://read.qxmd.com/read/38680153/antimicrobial-effects-of-catnip-nepeta-catari-a-l-essential-oil-against-canine-skin-infection-pathogens
#3
JOURNAL ARTICLE
Glenn Neville Borlace, Ranee Singh, Supawadee Seubsasana, Pranom Chantaranothai, Eakachai Thongkham, Jareerat Aiemsaard
BACKGROUND AND AIM: Catnip essential oils have antimicrobial effects against bacteria, yeast, and fungi; however, there is limited information regarding their antimicrobial activity against pathogens that cause canine skin infections. This study aimed to identify the phytochemical constituents of catnip essential oil and assay its antimicrobial activity against Staphylococcus pseudintermedius , Malassezia pachydermatis , Microsporum canis , Microsporum gypseum , Microsporum gallinae , and Trichophyton mentagrophytes ...
March 2024: Veterinary World
https://read.qxmd.com/read/38672512/effects-of-cannabidiol-%C3%A2-9-tetrahydrocannabinol-and-win-55-212-22-on-the-viability-of-canine-and-human-non-hodgkin-lymphoma-cell-lines
#4
JOURNAL ARTICLE
Saba Omer, Suhrud Pathak, Mahmoud Mansour, Rishi Nadar, Dylan Bowen, Muralikrishnan Dhanasekaran, Satyanarayana R Pondugula, Dawn Boothe
In our previous study, we demonstrated the impact of overexpression of CB1 and CB2 cannabinoid receptors and the inhibitory effect of endocannabinoids (2-arachidonoylglycerol (2-AG) and Anandamide (AEA)) on canine ( Canis lupus familiaris) and human ( Homo sapiens ) non-Hodgkin lymphoma (NHL) cell lines' viability compared to cells treated with a vehicle. The purpose of this study was to demonstrate the anti-cancer effects of the phytocannabinoids, cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC), and the synthetic cannabinoid WIN 55-212-22 (WIN) in canine and human lymphoma cell lines and to compare their inhibitory effect to that of endocannabinoids...
April 19, 2024: Biomolecules
https://read.qxmd.com/read/38668767/septin-coated-microtubules-promote-maturation-of-multivesicular-bodies-by-inhibiting-their-motility
#5
JOURNAL ARTICLE
Benjamin P Robinson, Naomi R Bass, Priyanka Bhakt, Elias T Spiliotis
The microtubule cytoskeleton consists of microtubule subsets with distinct compositions of microtubule-associated proteins, which instruct the position and traffic of subcellular organelles. In the endocytic pathway, these microtubule-associated cues are poorly understood. Here, we report that in MDCK cells, endosomes with multivesicular body (MVB) and late endosome (LE) markers localize preferentially to microtubules coated with septin GTPases. Compared with early endosomes, CD63-containing MVBs/LEs are largely immotile on septin-coated microtubules...
August 5, 2024: Journal of Cell Biology
https://read.qxmd.com/read/38668417/limited-clinical-efficacy-with-potential-adverse-events-in-a-pilot-study-of-autologous-adoptive-cell-therapy-in-canine-oral-malignant-melanoma
#6
JOURNAL ARTICLE
Yuan-Yuan Xia, Kwan-Hwa Chi, Albert Taiching Liao, Jih-Jong Lee
Adoptive cell therapy (ACT) has been studied in several human and canine cancers with some promising clinical outcomes but not in canine oral malignant melanoma (OMM). Our manuscript aimed to explore one kind of ACT, the ex vivo-expanded autologous immune cell infusion in canine OMM, as this tumor remains a treatment dilemma. The study recruited dogs with histopathological diagnoses of oral malignant melanoma, generated their peripheral blood mononuclear cells, expanded them into predominantly non-B non-T cells via stimulations of IL-15, IL-2, and IL-21, and then re-infused the cells into tumor-bearing dogs...
March 28, 2024: Veterinary Sciences
https://read.qxmd.com/read/38662527/safety-and-biologic-activity-of-a-canine-anti-cd20-monoclonal-antibody-in-dogs-with-diffuse-large-b-cell-lymphoma
#7
JOURNAL ARTICLE
Gretchen P McLinden, Anne C Avery, Heather L Gardner, Kelley Hughes, Angie M Rodday, Kexuan Liang, Cheryl A London
BACKGROUND: To explore the safety and utility of combining low dose single-agent doxorubicin with a canine specific anti-CD20 monoclonal antibody (1E4-cIgGB) in client owned dogs with untreated B-cell lymphoma. ANIMALS: Forty-two client-owned dogs with untreated B-cell lymphoma. METHODS: A prospective, single arm, open label clinical trial of dogs with B-cell lymphoma were enrolled to receive 1E4-cIgGB and doxorubicin in addition to 1 of 3 immunomodulatory regimens...
April 25, 2024: Journal of Veterinary Internal Medicine
https://read.qxmd.com/read/38658617/single-cell-rna-sequencing-reveals-the-cellular-and-molecular-heterogeneity-of-treatment-na%C3%A3-ve-primary-osteosarcoma-in-dogs
#8
JOURNAL ARTICLE
Dylan T Ammons, Leone S Hopkins, Kathryn E Cronise, Jade Kurihara, Daniel P Regan, Steven Dow
Osteosarcoma (OS) is a heterogeneous, aggressive malignancy of the bone that disproportionally affects children and adolescents. Therapeutic interventions for OS are limited, which is in part due to the complex tumor microenvironment (TME). As such, we used single-cell RNA sequencing (scRNA-seq) to describe the cellular and molecular composition of the TME in 6 treatment-naïve dogs with spontaneously occurring primary OS. Through analysis of 35,310 cells, we identified 41 transcriptomically distinct cell types including the characterization of follicular helper T cells, mature regulatory dendritic cells (mregDCs), and 8 tumor-associated macrophage (TAM) populations...
April 24, 2024: Communications Biology
https://read.qxmd.com/read/38657233/first-in-human-stage-iii-iv-melanoma%C3%A2-clinical-trial-of-immune-priming-agent-ifx-hu2-0
#9
JOURNAL ARTICLE
Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Delhawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari Pilon-Thomas
IFx-Hu2.0 was designed to encode part of the Emm55 protein contained within a plasmid in a formulation intended for transfection into mammalian cells. IFx-Hu2.0 promotes both adaptive and innate immune responses in animal studies. Furthermore, previous studies have demonstrated safety/efficacy in equine, canine, and murine species. We present the first-in-human study of IFx-Hu2.0, administered by intralesional injection into melanoma tumors of seven patients with stage III/IV unresectable melanoma. No dose-limiting toxicities attributable to IFx-Hu2...
April 24, 2024: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38647163/tumor-associated-macrophages-and-tumor-infiltrating-lymphocytes-in-canine-cutaneous-and-subcutaneous-mast-cell-tumors
#10
JOURNAL ARTICLE
Luca Bertola, Benedetta Pellizzoni, Chiara Giudice, Valeria Grieco, Roberta Ferrari, Lavinia E Chiti, Damiano Stefanello, Martina Manfredi, Donatella De Zani, Camilla Recordati
Cutaneous and subcutaneous mast cell tumors (MCTs) are common canine neoplasms characterized by variable biological behavior. Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) can be effective prognostic markers in numerous human neoplasms and are increasingly investigated in dogs. The aim of this study was to characterize immune cells in canine MCTs and their relationship with histological location (cutaneous, subcutaneous) and histologic nodal metastatic status (HN0-3). Thirty-eight MCTs (26 cutaneous, 12 subcutaneous) from 33 dogs with known sentinel lymph node (SLN) metastatic status were immunolabeled for Iba1 (macrophages), CD20 (B cells), CD3 (T cells), and Foxp3 (regulatory T cells)...
April 22, 2024: Veterinary Pathology
https://read.qxmd.com/read/38622430/presumed-pseudo-pelger-hu%C3%A3-t-anomaly-and-basophilia-secondary-to-chronic-lymphocytic-leukemia-in-a-dog
#11
Javier Martínez-Caro, Beatriz Agulla, Clàudia Viñeta, Xavier Roura, Montse Mesalles, Josep Pastor
A 10-year-old neutered male Maltese dog was presented for an investigation of lymphocytosis. The dog was up-to-date on vaccinations and deworming. Physical examination did not reveal any significant abnormalities. A complete blood cell count (CBC) showed mild leukocytosis with moderate lymphocytosis, basophilia, and moderate neutropenia, but no significant left shift or toxic change. Serum biochemistry and urinalysis were unremarkable. All performed tests for infectious agents common in this geographical region were negative...
April 15, 2024: Veterinary Clinical Pathology
https://read.qxmd.com/read/38621412/immunotherapy-with-genetically-engineered-t-cells-holds-promise-for-the-treatment-of-nonmalignant-diseases-in-the-dog
#12
JOURNAL ARTICLE
Nicola J Mason
The ability to genetically redirect the antigenic specificity of T cells using chimeric antigen receptors (CAR) has led to unprecedented durable clinical remissions in human patients with relapsed/refractory hematological malignancies. This remarkable advance in successful immune cell engineering has now led to investigations into the application of CAR-T-cell technology to treat nonmalignant diseases. The use of CAR-T cells to target and eliminate specific cell subsets involved in the pathogenesis of autoimmunity, fibrosis, senescence, and infectious disease represents a new direction for adoptive cell therapies...
April 16, 2024: Journal of the American Veterinary Medical Association
https://read.qxmd.com/read/38616055/alternating-rabacfosadine-and-doxorubicin-for-treatment-of-na%C3%A3-ve-canine-lymphoma
#13
JOURNAL ARTICLE
Corey F Saba, Timothy M Fan, Brenda S Phillips, Zachary M Wright, Douglas H Thamm
The current standard of care treatment for canine lymphoma is a multi-agent, CHOP-based chemotherapy protocol. Single agent doxorubicin (DOX) is less burdensome; however, multi-agent chemotherapy protocols are often superior. The recently approved drug rabacfosadine (RAB, Tanovea) provides an attractive option for combination therapy with DOX, as both drugs demonstrate efficacy against lymphoma and possess different mechanisms of action. A previous study evaluating alternating RAB/DOX reported an overall response rate (ORR) of 84%, with a median progression-free survival time (PFS) of 194 days...
April 14, 2024: Veterinary and Comparative Oncology
https://read.qxmd.com/read/38614099/itpripl1-binds-cd3%C3%AE%C2%B5-to-impede-t%C3%A2-cell-activation-and-enable-tumor-immune-evasion
#14
JOURNAL ARTICLE
Shouyan Deng, Yibo Zhang, Huanbin Wang, Wenhua Liang, Lu Xie, Ning Li, Yuan Fang, Yiting Wang, Jiayang Liu, Hao Chi, Yufan Sun, Rui Ye, Lishen Shan, Jiawei Shi, Zan Shen, Yonggang Wang, Shuhang Wang, Jean-Philippe Brosseau, Feng Wang, Grace Liu, Yingfei Quan, Jie Xu
Cancer immunotherapy has transformed treatment possibilities, but its effectiveness differs significantly among patients, indicating the presence of alternative pathways for immune evasion. Here, we show that ITPRIPL1 functions as an inhibitory ligand of CD3ε, and its expression inhibits T cells in the tumor microenvironment. The binding of ITPRIPL1 extracellular domain to CD3ε on T cells significantly decreased calcium influx and ZAP70 phosphorylation, impeding initial T cell activation...
April 5, 2024: Cell
https://read.qxmd.com/read/38613431/safety-profile-and-effects-on-the-peripheral-immune-response-of-fecal-microbiota-transplantation-in-clinically-healthy-dogs
#15
JOURNAL ARTICLE
Mary Ann Lee, Maria Questa, Patrawin Wanakumjorn, Amir Kol, Bridget McLaughlin, Bart C Weimer, Agostino Buono, Jan S Suchodolski, Sina Marsilio
BACKGROUND: Fecal microbiota transplantation (FMT) is increasingly used for gastrointestinal and extra-gastrointestinal diseases in veterinary medicine. However, its effects on immune responses and possible adverse events have not been systematically investigated. HYPOTHESIS/OBJECTIVES: Determine the short-term safety profile and changes in the peripheral immune system after a single FMT administration in healthy dogs. ANIMALS: Ten client-owned, clinically healthy dogs as FMT recipients, and 2 client-owned clinically healthy dogs as FMT donors...
April 13, 2024: Journal of Veterinary Internal Medicine
https://read.qxmd.com/read/38607285/unveiling-the-role-of-endoplasmic-reticulum-stress-pathways-in-canine-demodicosis
#16
JOURNAL ARTICLE
Pamela A Kelly, Gillian P McHugo, Caitriona Scaife, Susan Peters, M Lynn Stevenson, Jennifer S McKay, David E MacHugh, Irene Lara Saez, Rory Breathnach
Canine demodicosis is a prevalent skin disease caused by overpopulation of a commensal species of Demodex mite, yet its precise cause remains unknown. Research suggests that T-cell exhaustion, increased immunosuppressive cytokines, induction of regulatory T cells and increased expression of immune checkpoint inhibitors may contribute to its pathogenesis. This study aimed to gain a deeper understanding of the molecular changes occurring in canine demodicosis using mass spectrometry and pathway enrichment analysis...
April 2024: Parasite Immunology
https://read.qxmd.com/read/38573683/applications-and-opportunities-for-immune-cell-car-engineering-in-comparative-oncology
#17
JOURNAL ARTICLE
Antonia Rotolo, Matthew J Atherton
Chimeric antigen receptor (CAR) T adoptive cell therapy has transformed the treatment of human hematologic malignancies. However, its application for the treatment of solid tumors remains challenging. An exciting avenue for advancing this field lies in the use of pet dogs, in which cancers that recapitulate the biology, immunological features, and clinical course of human malignancies arise spontaneously. Moreover, their large size, outbred genetic background, shared environment with humans, and immunocompetency make dogs ideal for investigating and optimizing CAR therapies before human trials...
April 4, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38561226/age-related-brain-atrophy-and-the-positive-effects-of-behavioral-enrichment-in-middle-aged-beagles
#18
JOURNAL ARTICLE
Jessica A Noche, Hamsanandini Radhakrishnan, Margo F Ubele, Kathy Boaz, Jennifer L Mefford, Erin D Jones, Jessica A Perpich, Katie McCarty, Beverly Meacham, Jeffrey Smiley, Stasia A Bembenek Bailey, László G Puskás, David K Powell, Lorena Sordo, Michael J Phelan, Christopher M Norris, Elizabeth Head, Craig E L Stark
Aging dogs serve as a valuable preclinical model for Alzheimer's disease (AD) due to their natural age-related development of beta-amyloid (Aβ) plaques, human-like metabolism, and large brains that are ideal for studying structural brain aging trajectories from serial neuroimaging. Here we examined the effects of chronic treatment with the calcineurin inhibitor (CNI) tacrolimus or the nuclear factor of activated T cells (NFAT)-inhibiting compound Q134R on age-related canine brain atrophy from a longitudinal study in middle-aged beagles (36 females, 7 males) undergoing behavioral enrichment...
April 1, 2024: Journal of Neuroscience
https://read.qxmd.com/read/38554158/targeting-osteosarcoma-with-canine-b7-h3-car-t-cells-and-impact-of-cxcr2-co-expression-on-functional-activity
#19
JOURNAL ARTICLE
Jennifer W Cao, Jessica Lake, Renata Impastato, Lyndah Chow, Luisanny Perez, Laura Chubb, Jade Kurihara, Michael R Verneris, Steven Dow
The use of large animal spontaneous models of solid cancers, such as dogs with osteosarcoma (OS), can help develop new cancer immunotherapy approaches, including chimeric antigen receptor (CAR) T cells. The goal of the present study was to generate canine CAR T cells targeting the B7-H3 (CD276) co-stimulatory molecule overexpressed by several solid cancers, including OS in both humans and dogs, and to assess their ability to recognize B7-H3 expressed by canine OS cell lines or by canine tumors in xenograft models...
March 30, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38553798/effect-of-leukoreduction-on-the-omics-phenotypes-of-canine-packed-red-blood-cells-during-refrigerated-storage
#20
JOURNAL ARTICLE
Arianna Miglio, Francesca Rocconi, Valentina Cremoni, Angelo D'Alessandro, Julie A Reisz, Mark Maslanka, Ian S Lacroix, Daniela Di Francesco, Maria T Antognoni, Morena Di Tommaso
BACKGROUND: Red blood cell (RBC) storage promotes biochemical and morphological alterations, collectively referred to as storage lesions (SLs). Studies in humans have identified leukoreduction (LR) as a critical processing step that mitigates SLs. To date no study has evaluated the impact of LR on metabolic SLs in canine blood units using omics technologies. OBJECTIVE: Compare the lipid and metabolic profiles of canine packed RBC (pRBC) units as a function of LR in fresh and stored refrigerated (up to 42 days) units...
March 29, 2024: Journal of Veterinary Internal Medicine
keyword
keyword
49005
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.